Circulating tumour DNA and resistance mechanisms during EGFR inhibitor therapy in lung cancer

Por Escriu, Carles, Field, John K.
Publicado no J Thorac Dis (2016)

The potential for using risk models in future lung cancer screening trials

Por Field, John K, Raji, Olaide Y
Publicado em 2010

Electronic cigarettes: a survey of perceived patient use and attitudes among members of the British thoracic oncology group

Por Sherratt, Frances C., Newson, Lisa, Field, John K.
Publicado no Respir Res (2016)

Risk assessment in relation to the detection of small pulmonary nodules

Por Field, John K., Marcus, Michael W., Oudkerk, Matthijs
Publicado no Transl Lung Cancer Res (2017)

Lung cancer screening: identifying the high risk cohort

Por Marcus, Michael W., Raji, Olaide Y., Field, John K.
Publicado no J Thorac Dis (2015)

Patient selection for future lung cancer computed tomography screening programmes: lessons learnt post National Lung Cancer Screening Trial

Por Field, John K., Duffy, Stephen W., Baldwin, David R.
Publicado no Transl Lung Cancer Res (2018)

Impact of comorbidity on lung cancer mortality - a report from the Liverpool Lung Project

Por MARCUS, MICHAEL W, CHEN, YING, DUFFY, STEPHEN W, FIELD, JOHN K
Publicado no Oncol Lett (2015)

Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing

Por Shaw, Richard J., Akufo-Tetteh, Emily K., Risk, Janet M., Field, John K., Liloglou, Triantafillos
Publicado em 2006

COL1A1, PRPF40A, and UCP2 correlate with hypoxia markers in non-small cell lung cancer

Por Oleksiewicz, Urszula, Liloglou, Triantafillos, Tasopoulou, Kalliopi-Maria, Daskoulidou, Nikoleta, Gosney, John R., Field, John K., Xinarianos, George
Publicado no J Cancer Res Clin Oncol (2017)

Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction model

Por MARCUS, MICHAEL W., RAJI, OLAIDE Y., DUFFY, STEPHEN W., YOUNG, ROBERT P., HOPKINS, RAEWYN J., FIELD, JOHN K.
Publicado no Int J Oncol (2016)

Impact of low-dose CT screening on smoking cessation among high-risk participants in the UK Lung Cancer Screening Trial

Por Brain, Kate, Carter, Ben, Lifford, Kate J, Burke, Olivia, Devaraj, Anand, Baldwin, David R, Duffy, Stephen, Field, John K
Publicado no Thorax (2017)

Predictive Accuracy of the Liverpool Lung Project Risk Model for Stratifying Patients for Computed Tomography Screening for Lung Cancer: A Case–Control and Cohort Validation Study...

Por Raji, Olaide Y., Duffy, Stephen W., Agbaje, Olorunshola F., Baker, Stuart G., Christiani, David C., Cassidy, Adrian, Field, John K.
Publicado em 2012

P1.04: Defining the Genetic Architecture of Lung Cancer Etiology

Por Amos, Christopher I., Hung, Rayjean, Bosse, Yohan, Christiani, David C., Field, John K., Landi, Maria T., Brennan, Paul B., Mckay, James P.
Publicado no J Thorac Oncol (2016)

Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry

Por Ehrich, Mathias, Nelson, Matthew R., Stanssens, Patrick, Zabeau, Marc, Liloglou, Triantafillos, Xinarianos, George, Cantor, Charles R., Field, John K., van den Boom, Dirk
Publicado em 2005

Alterations of the p16-pRb Pathway and the Chromosome Locus 9p21–22 in Non-Small-Cell Lung Carcinomas : Relationship with p53 and MDM2 Protein Expression

Por Gorgoulis, Vassilis G., Zacharatos, Panayotis, Kotsinas, Athanassios, Liloglou, Triantofillos, Kyroudi, Aspasia, Veslemes, Marinos, Rassidakis, Antonios, Halazonetis, Thanos D., Field, John K., Kittas, Christos
Publicado em 1998

DNA methylation biomarkers offer improved diagnostic efficiency in lung cancer

Por Nikolaidis, Georgios, Raji, Olaide Y, Markopoulou, Soultana, Gosney, John R, Bryan, Julie, Warburton, Chris, Walshaw, Martin, Sheard, John, Field, John K, Liloglou, Triantafillos
Publicado em 2012

AURKA mRNA expression is an independent predictor of poor prognosis in patients with non-small cell lung cancer

Por Al-Khafaji, Ahmed S.K., Marcus, Michael W., Davies, Michael P.A., Risk, Janet M., Shaw, Richard J., Field, John K., Liloglou, Triantafillos
Publicado no Oncol Lett (2017)

Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial

Por Brain, Kate, Lifford, Kate J, Carter, Ben, Burke, Olivia, McRonald, Fiona, Devaraj, Anand, Hansell, David M, Baldwin, David, Duffy, Stephen W, Field, John K
Publicado no Thorax (2016)

Aurora B expression modulates paclitaxel response in non-small cell lung cancer

Por Al-Khafaji, Ahmed SK, Davies, Michael PA, Risk, Janet M, Marcus, Michael W, Koffa, Maria, Gosney, John R, Shaw, Richard J, Field, John K, Liloglou, Triantafillos
Publicado no Br J Cancer (2017)

Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial

Por Ali, Noor, Lifford, Kate J, Carter, Ben, McRonald, Fiona, Yadegarfar, Ghasem, Baldwin, David R, Weller, David, Hansell, David M, Duffy, Stephen W, Field, John K, Brain, Kate
Publicado no BMJ Open (2015)